Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orlistat with Behavioral Therapy for Obesity and Binge Eating in Hispanics
NCT00516919Phase 4Completed
- Sponsor
- Yale University
- Start
- Aug 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obesity and binge eating disorder (BED) comparing Xenical + behavioral intervention with Placebo + behavioral intervention (2 arms). Primary endpoint: Participant Body Mass Index at 6 months. Started Aug 2007; status: completed.
02
Drugs
orlistat
03
Conditions
obesitybinge eating disorder (BED)
Beyond the preview
Go deeper on NCT00516919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00516919.